Compare TB-500, GLOW and KLOW
The useful comparison starts with what was actually in the experiment, then asks where the result was measured.
Ingredients and experimental materials
| Name | Material described | Research to distinguish |
|---|---|---|
| TB-500 | Synthetic 7-amino-acid actin-binding fragment | Most repair and human safety evidence uses full 43-amino-acid thymosin beta-4. |
| GLOW | GHK-Cu, BPC-157 and TB-500 | Topical GHK-Cu, animal BPC-157 and full-protein thymosin experiments concern separate materials. |
| KLOW | The GLOW ingredients plus KPV | The KPV intestinal-cell and mouse-colitis work introduces another setting and route. |
The full-protein review, GHK skin review and KPV transport study make those distinctions visible. Before attempting a ranking, I need the experimental material beside the headline result.
What has reached human studies?
The thymosin beta-4 Phase 1 study involved 40 healthy volunteers and used the full protein. The BPC-157 intravenous pilot involved two healthy adults. The 2025 BPC-157 review describes three small human pilot studies overall, alongside a much larger preclinical literature.
Topical GHK-Cu has skin research reviewed in 2015. KPV’s intestinal inflammation study used cultured cells and mice. None of those studies tested the full GLOW or KLOW combination. The different routes matter too: topical skin evidence cannot establish the effects of an injected blend.
I cannot produce a credible winner from these unlike experiments. The evidence gives a set of questions for each substance, with particularly large gaps around the mixtures.
The comparison that would settle more
A useful blend experiment would compare the complete mixture with its constituent ingredients under the same conditions. It would measure a defined tissue outcome and adverse effects, then follow exposure to the components. No controlled study has made that comparison for GLOW or KLOW.
A functional measure gets my vote wherever one is possible. The rat Achilles BPC-157 study included biomechanical testing, so there was a direct question about what the repaired tendon could bear. Skin appearance, inflammatory signals and tissue strength each deserve their own outcomes rather than being collapsed into “repair.”